Researchers find no improvement in ICU death rate at minority-serving hospitals

Researchers find no improvement in ICU death rate at minority-serving hospitals

Hospital readmission program not associated with increased risk of death in patients The team found a steady annual decline of two percent in ICU deaths at non-minority hospitals; however, the same improvement in mortality rate was not seen at minority-serving hospitals. Minority-serving hospitals also reported longer lengths of ICU stay and critical illness hospitalizations than non-minority hospitals. In addition to the disparity for all ICU patients seen in minority-serving hospitals, the researchers observed a particularly stark difference in care for critically ill African-American patients. African-Americans treated at non-minority hospitals experienced a three percent decline in mortality each year, compared to no decline in mortality when treated at minority-serving hospitals. While the study does not determine whether the outcomes at minority-serving hospitals are due to differences in hospital resources and practices or a systemic disparity of these patient populations, the findings highlight the profound obstacles minorities and minority-serving hospitals face. Although our analysis does not resolve the reasons for differences in outcomes, it identifies minority serving hospitals as an area of great need. Focusing research efforts to further address these inequalities is critical in mitigating the disadvantages minorities face and ultimately closing the health care divide. John Danziger, a nephrologist at BIDMC Source: Beth Israel Deaconess Medical Center Journal reference: Danziger, J. et al . (2020) Temporal Trends in Critical Care Outcomes in United States Minority Serving Hospitals. American Journal of Respiratory and Critical Care Medicine . doi.org/10.1164/rccm.201903-0623OC



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More